AU768489B2 - Cells for the production of helper dependent adenoviral vectors, method for the preparation and use thereof - Google Patents

Cells for the production of helper dependent adenoviral vectors, method for the preparation and use thereof Download PDF

Info

Publication number
AU768489B2
AU768489B2 AU12945/00A AU1294500A AU768489B2 AU 768489 B2 AU768489 B2 AU 768489B2 AU 12945/00 A AU12945/00 A AU 12945/00A AU 1294500 A AU1294500 A AU 1294500A AU 768489 B2 AU768489 B2 AU 768489B2
Authority
AU
Australia
Prior art keywords
cells
unit
regions
genic
cells according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU12945/00A
Other languages
English (en)
Other versions
AU1294500A (en
Inventor
Stefano Colloca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Publication of AU1294500A publication Critical patent/AU1294500A/en
Application granted granted Critical
Publication of AU768489B2 publication Critical patent/AU768489B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU12945/00A 1998-11-06 1999-11-08 Cells for the production of helper dependent adenoviral vectors, method for the preparation and use thereof Ceased AU768489B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM98A000694 1998-11-06
IT1998RM000694A IT1302403B1 (it) 1998-11-06 1998-11-06 Cellule per la produzione di vettori adenovirali difettivi, metodoper la loro preparazione e loro uso.
PCT/IT1999/000356 WO2000028060A2 (en) 1998-11-06 1999-11-08 Cells for the production of helper dependent adenoviral vectors

Publications (2)

Publication Number Publication Date
AU1294500A AU1294500A (en) 2000-05-29
AU768489B2 true AU768489B2 (en) 2003-12-11

Family

ID=11406205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12945/00A Ceased AU768489B2 (en) 1998-11-06 1999-11-08 Cells for the production of helper dependent adenoviral vectors, method for the preparation and use thereof

Country Status (9)

Country Link
US (1) US6890528B1 (https=)
EP (1) EP1127149B1 (https=)
JP (1) JP2002535961A (https=)
AT (1) ATE338825T1 (https=)
AU (1) AU768489B2 (https=)
CA (1) CA2349594C (https=)
DE (1) DE69933131T2 (https=)
IT (1) IT1302403B1 (https=)
WO (1) WO2000028060A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY139948A (en) * 2000-09-28 2009-11-30 Bayer Corp Enhanced transfection system
US7723102B2 (en) 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system
DE602004010112T2 (de) * 2004-09-14 2008-09-18 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) In cis regulierte konditionelle Genvektoren
GB202410992D0 (en) * 2024-07-26 2024-09-11 Icosphere Biosciences Ltd Process for making gutless helper-dependent adenoviruses

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997000326A1 (en) * 1995-06-15 1997-01-03 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
WO1998013570A1 (de) * 1996-09-26 1998-04-02 Hörmann KG Antriebstechnik Zahnscheibenhalter für torantriebe
WO1999064577A1 (en) * 1998-06-09 1999-12-16 Merck & Co., Inc. Novel adenoviral vectors for gene therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080569A (en) * 1993-06-24 2000-06-27 Merck & Co., Inc. Adenovirus vectors generated from helper viruses and helper-dependent vectors
FR2716459B1 (fr) 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.
FR2738575B1 (fr) 1995-09-08 1997-10-10 Centre Nat Rech Scient Cellules pour la production d'adenovirus recombinants
US6228646B1 (en) 1996-03-07 2001-05-08 The Regents Of The University Of California Helper-free, totally defective adenovirus for gene therapy
NZ334827A (en) * 1996-09-25 2001-02-23 Scripps Research Inst High-capacity adenoviral vectors suitable for adenoviral-based gene therapy
CA2340276A1 (en) * 1998-08-28 2000-03-09 Duke University Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997000326A1 (en) * 1995-06-15 1997-01-03 Introgene B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
WO1998013570A1 (de) * 1996-09-26 1998-04-02 Hörmann KG Antriebstechnik Zahnscheibenhalter für torantriebe
WO1999064577A1 (en) * 1998-06-09 1999-12-16 Merck & Co., Inc. Novel adenoviral vectors for gene therapy

Also Published As

Publication number Publication date
DE69933131T2 (de) 2007-03-29
WO2000028060A3 (en) 2000-10-05
IT1302403B1 (it) 2000-09-05
ATE338825T1 (de) 2006-09-15
CA2349594A1 (en) 2000-05-18
US6890528B1 (en) 2005-05-10
DE69933131D1 (de) 2006-10-19
ITRM980694A0 (it) 1998-11-06
EP1127149B1 (en) 2006-09-06
AU1294500A (en) 2000-05-29
EP1127149A2 (en) 2001-08-29
WO2000028060A2 (en) 2000-05-18
CA2349594C (en) 2007-02-06
ITRM980694A1 (it) 2000-05-06
JP2002535961A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
US6365394B1 (en) Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
EP0870049B1 (en) Complementary adenoviral vector systems and cell lines
AU687829B2 (en) Adenovirus vectors for gene therapy
WO1998039411A9 (en) Adenovirus e1-complementing cell lines
WO1998039411A1 (en) Adenovirus e1-complementing cell lines
Catalucci et al. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent ΔE1-E2-E3-E4 Ad5 vectors
AU752284B2 (en) Methods for pseudoadenoviral vector production
AU768489B2 (en) Cells for the production of helper dependent adenoviral vectors, method for the preparation and use thereof
US20010046965A1 (en) Adenovirus E1-complementing cell lines
EP1291434A2 (en) Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
EP1083229A1 (en) Modified adenoviral vectors for use in gene therapy
WO1998032860A1 (en) Methods for highly efficient generation of adenoviral vectors
WO2001034825A1 (en) Ptp/dna polymerase cell line as packaging cell line for minimal adenoviral vectors
Morris et al. Generation of cell lines to complement adenovirus vectors using recombination-mediated cassette exchange
WO2001020014A1 (en) Modified adenoviral vectors for use in gene therapy
US7585498B2 (en) Regulation of adenovirus DNA packaging by IPTG
WO2026022346A2 (en) Process for making gutless helper-dependent adenoviruses
Morsy et al. Helper-dependent adenoviral vectors as gene delivery vehicles

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)